Interruption of antifungal secondary prophylaxis in AIDS-related histoplasmosis;Interrupción de la profilaxis secundaria antifúngica en la histoplasmosis asociada al sida

Revista Iberoamericana de Micologia

Volumn 21, Issue 2, 2004, Pages 75-78

  Negroni, Ricardo ^a   Helou, Silvia H ^a   López Daneri, Gabriela ^a   Robles, Ana M ^a   Arechavala, Alicia I ^a   Bianchi, Mario H ^a  

^a HOSPITAL F J MUÑIZ   (Argentina)

Author keywords

AIDS; Histoplasmosis; Secondary prophylaxis interruption

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; ITRACONAZOLE; POSACONAZOLE;

ADULT; AIDS RELATED COMPLEX; ARTICLE; BACTERIAL PNEUMONIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; FUNGICIDAL ACTIVITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPLASMOSIS; HUMAN; INFECTION PREVENTION; KAPOSI SARCOMA; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; MALE; MEDICAL RECORD; SAMPLE SIZE; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIFUNGAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HISTOPLASMOSIS; HUMANS; MALE; MIDDLE AGED;

BACTERIA (MICROORGANISMS);

EID: 10644229248     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Alsip S, Dismukes WE. Approach to the patient with suspected histoplasmosis. In: Remington JS, Swart MN (Eds.) Current Clinical Topic in Infectious diseases. New York, Mc Graw-Hill, 1986: 254-296.
2. Arechayala A, Robles AM, Negroni R, Bianchi M, Taborda A. Valor de los métodos directos e indirectes de diagnóstico en las micosis asociadas al sida. Rev Inst Med Trop Sao Paulo 1993; 35: 163-169.
3. Bianchi M, Robles AM, Vitale R, Helou S, Arechavala A, Negroni R. The usefulness of blood cultures in the diagnosis of AIDS-related systemic mycoses: evaluation of a manual lysis-centrifugation method. Med Mycol 2000; 38: 77-80.
4. Caligari Costa L, Dalla Negra M, Ferreira MS, Kaplan J, Negroni R, Weissenbacher M. Normas para la prevenciȯn de las enfermedades oportunistas en las personas infectadas por el VIH. Reunion de expertos realizada en Montevideo del 7 al 8 de julio de 2003. En prensa.
5. a Ed). Buenos Aires, Ed. Médica Panamericana, 2002: 3289-3307.
6. a Ed.). Buenos Aires, Fundai, 2001: 53-96.
7. Kwon-Chung KJ, Bennett JE. Histoplasmosis. In: Kwon-Cnung KJ, Bennett JE (Eds.) Medical Mycology. Philadelphia, Lea & Febiger, 1992: 464-513.
8. Marques SA, Robles AM, Tortorano AM, Tuculet MA, Negroni R, Mendes RP. Mycoses associated with AIDS in the Third World. Med Mycol 2000; 38: 269-279.
9. Mc Kinsey DS, Wheat LJ, Cloud GA, Pierce M, Black JR, Baberg DM. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebe-controlled, double-blind study. Clin Infect Dis 1999; 28: 1049-1056.
10. Negroni R. Clinical spectrum and treatment of classic histoplasmosis. In: Kushwaha RKS, Guarro J. (Eds.) Biology of dermatophytes and other keratinophilic Fungi. Bilbao, Revista Iberoamericana de Micología, 2000: 159-162.
11. Negroni R. La histoplasmosis asociada al SIDA en los años del tratamiento antirretroviral (T.A.R.). El Muñiz Hoy 2000; 3: 102-107.
12. a Ed). Buenos Aires, Fundai, 2001: 301-332.
13. Negroni R, Robles AM, Arechavala A. Histoplasmosis progresiva. Estudio en un lapso de 10 años. Rev Argent Micol 1994; 17: 14-21.
14. Negroni R, Robles AM, Arechavala A, Bianchi M, Helou S. Histoplasmosis relacionada al SIDA, su estado actual en la Argentina. Prensa Médica Argentina 1997; 84: 696-700.
15. Wheat LJ. Histoplasma capsulatum (Histoplasmosis). In: Yu V, Weber R, Raoult E (Eds.) Antimicrobial Therapy and Vaccines. Volume I: Microbes (2nd Ed). New York, Apple Trees Production, 2002: 1069-1079.
16. Wheat LJ, Kauffman CA. Histoplasmosis. In: Walsh TJ, Rex JH (Eds.) Fungal Infections, Part II. Infect Dis Clin N Am 2003; 17: 1-19.
17. Wheat LJ, Slama TG, Zeckel ML. Histoplasmpsis in the acquired immunodeficiency syndrome. Am J Med 1985; 78: 203-210.